Project Details
| Status | Active |
|---|---|
| Effective start/end date | 01/31/23 → 12/8/26 |
Funding
- Biohaven Pharmaceuticals Holding Company Ltd.: $70,811.81
BHV2000-301: A Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy and Safety of Taldefgrobep Alfa in Ambulatory and Non-Ambulatory Participants with Spinal Muscular Atrophy with Open-Label Extension (RESILIENT)
- Treidler, Simona (PI)
- Dawson, Dawn Michelle (CoPI)
- Morelli, Peter (CoPI)
Project: Research